Device Trial Radar · NCT04683471
Pilot Trial of a System for Motor Function Recovery
Last checked: Nov 20, 2026Latest source record: Apr 13, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Nov 30, 2020
Primary completion
Dec 22, 2021
Study completion Mar 22, 2022
Sponsor
- Lead sponsor
- Niche Biomedical, Inc. dba ANEUVONot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 24, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Crossover
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, prospective, blinded, pilot feasibility study to evaluate improvement in sensory and motor function with sham.
Conditions
- Spinal Cord Diseases
Interventions
StimulatorDevice
Neuromodulation
ShamDevice
Sham
Primary outcomes
What the sponsor says the trial is designed to measure.
- Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)Time frame: Biweekly through study completion up to 18 weeks
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Shirley Ryan AbilityLab
Chicago, Illinois
Kennedy Krieger Institute
Baltimore, Maryland
Houston Methodist Research Institute
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.